CONMED Announces Full Market Release of the Paladin™ Suture Anchor for Rotator Cuff Repair

CONMED Corporation’s CONMED Linvatec arthroscopy unit announced today the full market release of the Paladin™ Rotator Cuff Suture Anchor System following its preview at the recent Spring Arthroscopy Association of North America Annual Meeting.

MRI Identifies Five Causes Of Complications From ACL Reconstructive Surgery

MRI has identified five possible causes of patient complications from anterior cruciate ligament reconstructive surgery, according to a study performed at Emory University Hospital in Atlanta, GA, and Sahlgrenska-Molndal University Hospital in Gothenborg, Sweden.

Hip Resurfacing Championed as a Bone-Preserving Alternative to Total Hip Replacement

According to Millennium Research Group’s US Markets for Large-Joint Reconstructive Implants 2009 report, hip resurfacing will be the fastest-growing segment of the large-joint reconstructive implant market through 2013, rising at a compound annual growth rate of over 25%.

Physical Activity Monitor Revolutionises Hip And Knee Surgery

A revolutionary new physical activity monitoring system which compares actual patient activity with researched norms for individual patient types has been unveiled to support orthopaedic surgeons and GPs in their decision making processes along the care pathway.

Harvard Study Favors Cayenne Medical’s AperFix Technology for Reconstruction of Torn ACL

Cayenne Medical, Inc. announced today that a new Harvard clinical study published in the American Journal of Sports Medicine found that Cayenne’s AperFix® System and “Single Tunnel, Double Bundle™” ACL reconstruction technique better resembles the natural, intact ACL when compared to the more common, “Single-Bundle” technique.

BioSyntech to Conduct Substantial Interim Analysis on Half of Enrolled Patients from BST-CarGel® Pivotal Trial

BioSyntech, Inc. today announced that it will conduct an interim analysis of the available clinical data from 40 subjects who have completed their 12 month follow-up in the 80 subject trial for its cartilage repair device, BST-CarGel®.

Blood Clots After Hip Or Knee Replacement Surgery – NICE Recommends Xarelto® (rivaroxaban) Use In NHS, UK

Bayer Schering Pharma welcome NICE’s Final Appraisal Determination giving a draft recommendation that Xarelto (rivaroxaban), within its marketing authorisation, is recommended as an option for the prevention of venous thromboembolism in adults having elective total hip or elective total knee replacement surgery.

Most read

Latest

^